ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NGG Nextgen

78.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Nextgen LSE:NGG London Ordinary Share GB00B7JRYW03 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 78.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Nextgen Share Discussion Threads

Showing 1201 to 1223 of 1275 messages
Chat Pages: 51  50  49  48  47  46  45  44  43  42  41  40  Older
DateSubjectAuthorDiscuss
22/2/2012
12:52
Many thanks Stephanie M
mypension
22/2/2012
12:42
Duplicated - Deleted

s

stephanie_m
22/2/2012
12:42
As requested:



s

stephanie_m
22/2/2012
10:37
Looks like 5 buys 3 sells bigger trades are buys though.
markmewerds
22/2/2012
10:31
Anyone with Level 2 - are those millions traded today buys or sells?
mypension
12/2/2012
15:19
sadly some here listened to the rampers rather than the thought-out views posted by myself from Apr last year
the_doctor
11/2/2012
02:50
Late reported,presume roll over, trade of 218 Million shares. The privelege cost the investor a fee of £3052.

s

stephanie_m
31/1/2012
09:07
Good luck SM, I've written these off. Once they get to .3p I'm out.(If they ever get there, that is).
bobby.ifa
30/1/2012
22:44
Added more!!.

s

stephanie_m
19/1/2012
08:26
Going to make a further speculative investment in NGG.

A takeover perhaps?

s

stephanie_m
14/12/2011
17:02
'Ann Arbor, Michigan, US, and London, UK, 6 December 2011 - NextGen Group plc (AIM:NGG) is pleased to announce that its US-subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has appointed Steve Zolnay as Vice President of Business Development for North America.'

where did their last guy go?? ;o)

the_doctor
14/12/2011
16:47
Look at all warrants, once exercised this company will be heavily diluted, killing the value for any current share-holders.
bobby.ifa
02/12/2011
11:57
Not sure how to read this news, I don't like the warning about the lack of protection afforded to us shareholders. Almost a precurser to imminent bad news.
bobby.ifa
14/11/2011
16:33
will be raising money q1 2012
moggey07
04/11/2011
14:00
Looks like one of duff investments eeking out its final year before bankruptcy.Doh!
Arrangement fee is outrageous.

bobby.ifa
04/11/2011
13:11
wow thats some payment. It costs them £123500 EU just to borrow the money and they still have to pay interest on top. Good game!
dubois
12/9/2011
18:09
Is this not due to raise cash very soon??

not a deramp, I'm just intrigued.
They may be able to get profitable on what they have, but unlike PRM, no larger deal prospects.

the_doctor
25/8/2011
06:35
6,994,542,570 people in the world.
About 1 share each :-)

awja
24/8/2011
06:59
7 billion shares in issue !
34simon
10/8/2011
08:44
Blimey, its been quiet on here, no post for 5 weeks. Wakey wakey, up 15%, but for how long?
bobby.ifa
03/7/2011
21:09
Probably

s

stephanie_m
03/7/2011
20:13
What the author really means is 'three microcap stocks that they were able to ramp in the extreme and generate enough buyer interest for ludicrous moves... and would like to ramp some more'
the_doctor
03/7/2011
17:21
July 2011's Penny Shares to Watch...

This month's penny shares to watch:

Why biotech will command the headlines this year...

Sareum Holdings (SAR), Valirx (VAL), Nextgen (NGG)

Three small cap 'internet cops' waging war on cybercrime...

Coreroc (CORO), Datatec (DTC), Digital Barriers (DGB), NCC Group (NCC)

To read more about this month's penny share tips take a no obligation trial now and INSTANTLY DOWNLOAD the latest issue PLUS get 3 free special reports!
Looking to invest in penny shares? Keep reading to discover my ideas for the coming month...



Why biotech will command the headlines this year
(This article first appeared in Penny Sleuth in June 2011. Penny Sleuth is an unregulated free e-letter written by Tom Bulford and published by MoneyWeek Limited)

This year has seen the dramatic revival of a small sector that has long been written off by most investors.

Until now, biotech has been the stuff of nightmares. The medical terminology is baffling. The process of medical discovery is long and expensive. But above all the vast sums of money poured into biotech have paid glorious salaries for chemists and biologists – but precious little to outside investors.

But a sea change in the industry could change all that. For years big pharma has lead the way in bringing blockbuster drugs to market. But they can't do it any longer. Racked by costs and under threat from generic drug developers, the big pharmaceuticals are stepping back from research.

And that opens the door for biotechs. Over the next few years I think it is likely to be biotech stocks that command the headlines in this industry. And the advances underway in biotech could prove hugely lucrative for penny investors...

stephanie_m
Chat Pages: 51  50  49  48  47  46  45  44  43  42  41  40  Older

Your Recent History

Delayed Upgrade Clock